Skip to main content
. 2023 Aug 23;23:790. doi: 10.1186/s12885-023-11181-x

Fig. 1.

Fig. 1

The patient selection criteria for the study cohort and validation cohort. PDAC, pancreatic ductal adenocarcinoma; NAT, neoadjuvant therapy; PNAT, prospective neoadjuvant therapy; UFS, upfront surgery; SEER, Surveillance, Epidemiology, and End, Results